Showing results (1751-1760 of 2,897) with videos related to

Sort By:
Pageof 290
Digestive Diseases (Basel, Switzerland)|May 20, 2021
Jaundice as a Diagnostic and Therapeutic Problem: A General Practitioner's ApproachAleksandra Pavlovic Markovic, Milica Stojkovic Lalosevic, Dragana Danilo Mijac, et al.
Psychiatry Research|May 23, 2021
Childhood maltreatment correlates with higher concentration of transforming growth factor beta (TGF-β) in adult patients with major depressive disorderAna Munjiza Jovanovic, Marija Mitkovic-Voncina, Milutin Kostic, et al.
International Journal of Molecular Sciences|March 10, 2022
Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated ActivationMilica Markovic, Karina Abramov-Harpaz, Clil Regev, et al.
Annals of the New York Academy of Sciences|July 27, 2000
Ga733/EpCAM as a target for passive and active specific immunotherapy in patients with colorectal carcinomaH Mellstedt, J Fagerberg, J E Frödin, et al.
Journal of Vascular Surgery|January 11, 2011
Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgeryIgor B Končar, Lazar B Davidović, Nebojsa Savić, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 17, 2012
Cytotoxic effects of glass ionomer cements on human dental pulp stem cells correlate with fluoride releaseTatjana Kanjevac, Marija Milovanovic, Vladislav Volarevic, et al.
Journal of the Neurological Sciences|August 13, 2018
Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's diseaseM Z Jankovic, V Dobricic, N Kresojevic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Vaccination with Ep-CAM protein or anti-idiotypic antibody induces Th1-biased response against MHC class I- and II-restricted Ep-CAM epitopes in colorectal carcinoma patientsSzilvia Mosolits, Katja Markovic, Jan-Erik Frödin, et al.
Pageof 290